Cardiac Rhythm Management
banner BSCI ACC 2019 SPAF

 

tmb BSCI ACC 2019 invite

Location:
JW Marriott New Orleans - Ballroom: ILE DE FRANCE III,
New Orleans, LA

Date:
Sunday, March 17, 2019


Time:

6:30PM-7:00PM: Registration with Cocktail Reception, Followed by Dinner Seating
7:00PM-9:30PM: Educational Program

Cardiac Rhythm Management

Agenda

Agenda    
6:30PM-7:00PM   Registration and Reception; Followed by Dinner Seating
7:00PM-7:05PM   Welcome and Opening Remarks
Vivek Reddy
    Session I
7:05PM-7:35PM   LAA Closure for Stroke Prevention
Moderator: Vivek Reddy
  Conceptual Basis of LAAC & Outcomes: Mortality and Net Clinical Benefit
Vivek Reddy
  Device-Related Thrombus: Incidence, Management & Outcomes
Miguel Valderrábano
  Why LAAC? Understanding Intracranial Hemorrhage Risk before It Happens
Edip Gurol
7:35PM-8:05PM   Recorded Case: Watchman-Flex Implantation
Case Origin - Mount Sinai Hospital
Operator:  William Whang
Moderator:  Vivek Reddy
Panel:  Edip Gurol and Miguel Valderrábano
    Session II
 8:05PM-8:50PM   AF-Related Stroke & Anticoagulation
Moderator:  Valentin Fuster
  NOAC Use in “Special Populations”: CKD, Liver Disease, Obesity, Elderly
Valentin Fuster
  Using NOAC Reversal Agents: When and How?
Jonathan Halperin
  Subclinical Atrial Fibrillation: Incidence and Management
Taya Glotzer
    Wearables in AF: Where are We? And Where are We Going?
Mintu Turakhia
8:50PM-9:30PM   Panel Discussion
Moderator:  Valentin Fuster
Panel:  Vivek Reddy, Johnathan Halperin, Taya Glotzer, and Mintu Turakhia
     

Cardiac Rhythm Management

Commercial Support

Educational support provided by:

Boston Scientific.

 

Course Organizer:

MediaSphere Medical, LLC

 

 

 

Faculty

Program Director

Vivek Reddy, MD
The Mount Sinai Hospital
New York, NY

Faculty

Valentin Fuster, MD, PhD, MACC
Director, Zena and Michael A. Wiener Cardiovascular Institute
The Mount Sinai Hospital
New York, NY

Edip Gurol, MD, MSc
Director of High Hemorrhage Risk Stroke Prevention Clinic  
Massachusetts General Hospital Neurology
Assistant Professor, Harvard Medical School
Boston, MA

Taya Glotzer, MD, FACC, FHRS
Hackensack University Medical Center
Hackensack, NJ

Jonathan Halperin, MD
Professor of Medicine, Cardiology
The Mount Sinai Hospital
New York, NY

Mintu Turakhia, MD, MAS
Center for Digital Health, Stanford University
VA Palo Alto Health Care System
Palo Alto, CA

Miguel Valderrábano, MD, FACC
Lois and Carl Davis Centennial Chair, DeBakey Heart & Vascular Center
Professor of Cardiology, Institute for Academic Medicine
Associate Member, Research Institute
Houston Methodist
Houston, TX

William Whang, MD
The Mount Sinai Hospital
New York, NY

 

 

 

Activity Description

Activity Description
This educational symposium features world-renowned experts who will explore recent advancements in oral anticoagulation therapy and Left Atrial Appendage Closure (LAAC) for managing Atrial Fibrillation (AF) related stroke. Featuring insightful rapid-fire presentations, expert panel discussions, an illustrative LAAC case demonstration, and engaging Q&A sessions, this symposium is a can’t miss meeting for physicians and associated healthcare professionals who seek to employ evidence-based therapeutic strategies for stroke prophylaxis in AF patients.

Target Audience
This activity has been developed to meet the educational needs of electrophysiologists, interventional cardiologists, cardiologists, surgeons, neurologists, and other physicians and associated healthcare professionals with an interest in the management of stroke in AF patients.

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Review NOAC use in special patient populations.
  • Assess real-world registry NOAC outcomes, including relative effectiveness and compliance. 
  • Examine factors to determine when NOACs replace anti-platelets.
  • Identify when and how to use NOAC reversal agents. 
  • Review incidence and management of subclinical Atrial Fibrillation.
  • Evaluate the conceptual basis of LAAC and outcomes, including mortality and net clinical benefit.
  • Examine device-related thrombus, including incidence, management and outcomes.

Cardiac Rhythm Management

 

Registration

Registration
  1. First Name: *  
    Invalid Input
  2. Middle Name:
    Invalid Input
  3. Last Name: *  
    Invalid Input
  4. Primary Email Address: *  
    Invalid Input
  5. Registration Type: *  
    Invalid Input
  6. Medical Specialty:
    Invalid Input
  7. Institution: *  
    Invalid Input
  8. Mailing Address:*  
    Invalid Input
  9. City: *  
    Invalid Input
  10. State: *  
    Invalid Input
  11. Zip Code:
    Invalid Input
  12. Country:
    Invalid Input
  13. Office Phone:
    Invalid Input
  14. Office Fax:
    Invalid Input
  15. (*) Required Fields
  16. Invalid Input

 

 

“This event is not part of ACC.19, as planned by its Program Committee, and does not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.”